Article
Version 1
Preserved in Portico This version is not peer-reviewed
Target Identification in Breast Cancer through Network Pharmacology
Version 1
: Received: 21 May 2024 / Approved: 24 May 2024 / Online: 24 May 2024 (08:38:01 CEST)
How to cite: Sonawane, M.; Badhe, P.; Mali, P. Target Identification in Breast Cancer through Network Pharmacology. Preprints 2024, 2024051605. https://doi.org/10.20944/preprints202405.1605.v1 Sonawane, M.; Badhe, P.; Mali, P. Target Identification in Breast Cancer through Network Pharmacology. Preprints 2024, 2024051605. https://doi.org/10.20944/preprints202405.1605.v1
Abstract
In this study, we utilized the UniProt database to extract breast cancer genes Total 2658 genes in Homo sapiens are obtain. Then 166 genes are taken and after delating duplicates 158 genes were remains. These genes were then analyzed for their biological pathways using Gene Ontology enrichment analysis through the Genecodis platform, resulting in the identification of 12 unique genes involved in disease pathways. Protein-protein interaction (PPI) network analysis was conducted using the STRING database and Cytoscape software, identifying ANLN,TREM1,LZTFL1,OXSM,PLA2G3,TAS2R13,ABCB10,ECT2,TRPC,BCAS3,PLA2G3,ZDHHC7 and ERBB2 as potential gene targets for breast cancer.
Keywords
breast cancer; genes; pathway analysis; protein protein interaction; degree and betweenness
Subject
Biology and Life Sciences, Life Sciences
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment